Rhenman & Partners Asset Management’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-804,649
|
|
||||
|
2024
Q3 | $4.88M | Sell |
804,649
-1,405
|
|
||||
|
2024
Q2 | $4.24M | Sell |
806,054
-105,766
|
|
||||
|
2024
Q1 | $7.74M | Buy |
911,820
+555,320
|
|
||||
|
2023
Q4 | $2.35M | Hold |
356,500
|
|
||||
|
2023
Q3 | $1.1M | Hold |
356,500
|
|
||||
|
2023
Q2 | $963K | Hold |
356,500
|
|
||||
|
2023
Q1 | $1.05M | Sell |
356,500
-18,500
|
|
||||
|
2022
Q4 | $945K | Hold |
375,000
|
|
||||
|
2022
Q3 | $1.35M | Hold |
375,000
|
|
||||
|
2022
Q2 | $1.18M | Sell |
375,000
-35,923
|
|
||||
|
2022
Q1 | $2.54M | Sell |
410,923
-9,077
|
|
||||
|
2021
Q4 | $5.93M | Sell |
420,000
-180,000
|
|
||||
|
2021
Q3 | $4.8M | Buy |
600,000
+340,000
|
|
||||
|
2021
Q2 | $7.43M | Hold |
260,000
|
|
||||
|
2021
Q1 | $7.55M | Buy |
260,000
+103,300
|
|
||||
|
2020
Q4 | $1.87M | Buy |
+156,700
|
|